(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1

Autor: Hu, Qinghua, Zhou, Mengze, Zhu, Haoran, Lu, Guo, Zheng, Dongsen, Li, Huanqiu, Hao, Kun
Zdroj: In Biomedicine & Pharmacotherapy February 2017 86:88-94
Databáze: ScienceDirect
Externí odkaz: